Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Perroni

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Acta Endocrinologica|March 1, 1976
Growth hormone and somatomedin behaviour in the newbornG Giodano, E Foppiani, F Minuto, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 1, 1993
Right ventricular metastasis from choriocarcinoma: report of a rare case and review of the literatureD Perroni, G L Grecchi, P La Ciura, et al.
Chirurgia Italiana|June 1, 1986
[Osteoid osteoma of the femur neck (report of a case)]F Odella, L Schiesari, G Gaetani, et al.
Minerva Chirurgica|September 30, 1988
[Neo-adjuvant chemotherapy]C Bumma, D Perroni, G L Grecchi, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1996
Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patientsS Bretti, A Berruti, G Gorzegno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter studyD Amadori, O Nanni, M Marangolo, et al.
Anticancer Research|July 1, 1997
Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survivalA Berruti, P Zola, T Buniva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trialL Dogliotti, A Berruti, T Buniva, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Acta Endocrinologica|March 1, 1976
Growth hormone and somatomedin behaviour in the newbornG Giodano, E Foppiani, F Minuto, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 1, 1993
Right ventricular metastasis from choriocarcinoma: report of a rare case and review of the literatureD Perroni, G L Grecchi, P La Ciura, et al.
Chirurgia Italiana|June 1, 1986
[Osteoid osteoma of the femur neck (report of a case)]F Odella, L Schiesari, G Gaetani, et al.
Minerva Chirurgica|September 30, 1988
[Neo-adjuvant chemotherapy]C Bumma, D Perroni, G L Grecchi, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1996
Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patientsS Bretti, A Berruti, G Gorzegno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter studyD Amadori, O Nanni, M Marangolo, et al.
Anticancer Research|July 1, 1997
Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survivalA Berruti, P Zola, T Buniva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trialL Dogliotti, A Berruti, T Buniva, et al.
Pageof 1